Startups
resTORbio is an advanced clinical stage company, developing medicines to treat aging-related diseases and conditions.
Overview
Location
United States, Massachusetts, Boston
Employees
11-50
Total raised
$40M
Founded date
2016
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 26, 2018 | resTORbio Announces Initial Public Offering Pricing | resTORbio, Inc., a Boston, MA-based clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, announced the pricing of its initial public off... |
| Jan 16, 2018 | Term Sheet — Tuesday, January 16 | CRYPTO ROADBLOCKS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Metropolitan Bank Holding Corp, which is used by cryptocurrency companies and investment firms for wire transfers and deposit... |
| Jan 2, 2018 | Term Sheet — Tuesday, January 2 | UBER’S RESET Happy New Year, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop UBER’S BIG DAY: SoftBank agreed to invest more than $7 billion in Uber for a 15% stake in the tech giant. According to me... |
| Dec 1, 2017 | Term Sheet — Friday, December 1 | DONE IN THE DARK Good morning, Term Sheet readers. Paid Content How can you protect what you can't see? From ExtraHop Over the years, these people say, Pishevar seemed to take a liking to Geidt, following her around at company events, and a... |
| Dec 1, 2017 | resTORbio Completes $40M Series B Financing | resTORbio, Inc., a Boston, MA-based clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, completed a $40m Series B financing round. The ... |
| Nov 30, 2017 | Rock Springs Capital Joins $40M Series B for ResTORbio | BOSTON--(BUSINESS WIRE)--resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, today announced the completion of an ov... |
| Nov 30, 2017 | Novartis-backed resTORbio raises $40M for aging disease trials | Boston biotech resTORbio has pocketed another $40 million from a second-round financing that it hopes gives it enough cash to move its lead candidate for respiratory tract infections in elderly patients into phase 3. The latest round brings... |
| Nov 30, 2017 | resTORbio Raises $40 Million | BOSTON--(BUSINESS WIRE)--resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, today announced the completion of an ov... |
| Nov 30, 2017 | resTORbio Inks $40M Series B Funding | BOSTON, MA, resTORbio today announced the completion of an oversubscribed $40 million Series B financing round. >> Click here for more funding data on resTORbio >> To export resTORbio funding data to PDF and Excel, click her... |
Reviews 0
FAQ about resTORbio
When was resTORbio founded?
resTORbio was founded in 2016.
How much funding has resTORbio raised?
resTORbio has raised $40M in total across 1 funding round.
What has the press written about resTORbio?
Parsers VC has collected 10 articles mentioning resTORbio, among them “resTORbio Announces Initial Public Offering Pricing” (Jan 26, 2018) and “Term Sheet — Tuesday, January 16” (Jan 16, 2018).
Is resTORbio still active?
Yes, resTORbio is active; its latest activity on Parsers VC dates from Jan 26, 2018.